News
The cost-effectiveness of the drug for NHS roll-out will now be assessed by the National Institute for Health and Care ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback